Total Funding
26
43
Total FundingVenture - Series Unknown raised
Growth Score
0 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
135129
First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD).
Anthony Opipari: Co-Founder and Chief Medical OfficerPast Role: IFM Therapeutics, Co-Founder- Gary Glick: CEO and FounderPast Role: Scorpion Therapeutics, Co-Founder, Chief Executive Officer
About the Company
First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD). The solutions include a gut-restricted small molecule that can be formulated for either oral or rectal administration to treat ulcerative colitis among other IBDs, giving UC patients more accessible and cost-effective
treatment.
